VIRIDIAN THERAPEUTICS INC (VRDN)
US92790C1045 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to VRDN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.03. This target is 207.34% above the current price.
VRDN was analyzed by 21 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about VRDN.
In the previous month the buy percentage consensus was at a similar level.
VRDN was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-21 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-03-20 | Needham | Maintains | Buy -> Buy |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-28 | Needham | Reiterate | Buy -> Buy |
| 2024-02-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-12-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-12-04 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-11-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-10-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-31 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-10-30 | Needham | Maintains | Buy -> Buy |
| 2023-09-13 | Stifel | Reiterate | Buy -> Buy |
| 2023-09-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-10 | Needham | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-08-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-09 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-07-11 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-07-11 | Needham | Reiterate | Buy -> Buy |
| 2023-07-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-07-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-14 | BTIG | Initiate | Buy |
| 2023-05-30 | RBC Capital | Initiate | Outperform |
| 2023-05-10 | JMP Securities | Maintains | Market Outperform |